ARCHIVES

Turmoil in Texas: DePinho Recommended AVEO Stock on CNBC Six Days After FDA Said New Trial Was Needed

This article is from The Cancer Letter archive.

Vol. 39 No. 19 | May 10, 2013

Download PDF Visit The Full Archive

Related Articles

Radium 223 Dichloride Reduces Death Risk By 30 Percent in Castration-Resistant Disease

August 30, 2013

To Industry for Development, NDA

November 18, 1977

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

Oxandrolone And Education Improves Weight Gain

February 28, 2003